| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration
|
Batty, G.D.
|
|
|
21 |
3 |
p. 646-654
|
artikel
|
| 2 |
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer
|
Capri, G.
|
|
|
21 |
3 |
p. 474-480
|
artikel
|
| 3 |
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer
|
Treat, J.A.
|
|
|
21 |
3 |
p. 540-547
|
artikel
|
| 4 |
A simple system for grading the response of breast cancer to neoadjuvant chemotherapy
|
Rodenhuis, S.
|
|
|
21 |
3 |
p. 481-487
|
artikel
|
| 5 |
Can proton MRS provide useful information for characterizing estrogen receptor status in breast cancer?
|
Baek, H.-M.
|
|
|
21 |
3 |
p. 663-665
|
artikel
|
| 6 |
CD26 expression in donor stem cell harvest and its correlation with engraftment in human haematopoietic stem cell transplantation: potential predictor of early engraftment
|
Prabhash, K.
|
|
|
21 |
3 |
p. 582-588
|
artikel
|
| 7 |
c-MYC depletion potentiates cisplatin-induced apoptosis in head and neck squamous cell carcinoma: involvement of TSP-1 up-regulation
|
Xu, B.
|
|
|
21 |
3 |
p. 670-672
|
artikel
|
| 8 |
Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study
|
Siena, S.
|
|
|
21 |
3 |
p. 655-661
|
artikel
|
| 9 |
Echinoside A, a new marine-derived anticancer saponin, targets topoisomerase2α by unique interference with its DNA binding and catalytic cycle
|
Li, M.
|
|
|
21 |
3 |
p. 597-607
|
artikel
|
| 10 |
Editorial board
|
|
|
|
21 |
3 |
p. ii-iii
|
artikel
|
| 11 |
EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer
|
Spindler, K.-L. G.
|
|
|
21 |
3 |
p. 535-539
|
artikel
|
| 12 |
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document
|
Arbyn, M.
|
|
|
21 |
3 |
p. 448-458
|
artikel
|
| 13 |
Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors
|
Bouchardy, C.
|
|
|
21 |
3 |
p. 459-465
|
artikel
|
| 14 |
Explaining variations in survival in breast cancer in the Eastern Region of England
|
Voogd, A.C.
|
|
|
21 |
3 |
p. 669-670
|
artikel
|
| 15 |
Expression of androgen receptors in primary breast cancer
|
Park, S.
|
|
|
21 |
3 |
p. 488-492
|
artikel
|
| 16 |
Fascin1 expression predicts poor prognosis in patients with nasopharyngeal carcinoma and correlates with tumor invasion
|
Wu, D.
|
|
|
21 |
3 |
p. 589-596
|
artikel
|
| 17 |
Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative
|
Cherny, N.I.
|
|
|
21 |
3 |
p. 615-626
|
artikel
|
| 18 |
Glycemic index and glycemic load: application in observational studies and association with hepatocellular carcinoma risk. Meaningful or error prone?
|
Jenab, M.
|
|
|
21 |
3 |
p. 437-439
|
artikel
|
| 19 |
Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer
|
Nadler, Y.
|
|
|
21 |
3 |
p. 466-473
|
artikel
|
| 20 |
Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial
|
Oh, B.
|
|
|
21 |
3 |
p. 608-614
|
artikel
|
| 21 |
Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)
|
Owadally, W.S.
|
|
|
21 |
3 |
p. 568-573
|
artikel
|
| 22 |
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients
|
Cappuzzo, F.
|
|
|
21 |
3 |
p. 562-567
|
artikel
|
| 23 |
in this issue
|
|
|
|
21 |
3 |
p. 435
|
artikel
|
| 24 |
IVS10+12A>G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer
|
Kim, J.G.
|
|
|
21 |
3 |
p. 525-529
|
artikel
|
| 25 |
Lapatinib and metronomic capecitabine combination in an HER2-positive inflammatory breast cancer patient: a case report
|
Montagna, E.
|
|
|
21 |
3 |
p. 667-668
|
artikel
|
| 26 |
Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen
|
Bertelli, G.
|
|
|
21 |
3 |
p. 498-505
|
artikel
|
| 27 |
Metabolic syndrome and cancer-related mortality among Korean men and women
|
Lee, J.S.
|
|
|
21 |
3 |
p. 640-645
|
artikel
|
| 28 |
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial
|
Tan, W.W.
|
|
|
21 |
3 |
p. 493-497
|
artikel
|
| 29 |
Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors
|
Schmid, P.
|
|
|
21 |
3 |
p. 633-639
|
artikel
|
| 30 |
Postoperative chemoradiotherapy in gastric cancer––a phase I–II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy
|
Jansen, E.P.M.
|
|
|
21 |
3 |
p. 530-534
|
artikel
|
| 31 |
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin–pemetrexed versus cisplatin–gemcitabine in advanced non-small-cell lung cancer
|
Syrigos, K.N.
|
|
|
21 |
3 |
p. 556-561
|
artikel
|
| 32 |
Relationship between NFKB1 -94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk
|
Zhou, B.
|
|
|
21 |
3 |
p. 506-511
|
artikel
|
| 33 |
Reply to Explaining variations in survival in breast cancer in the Eastern Region of England
|
Duffy, S.W.
|
|
|
21 |
3 |
p. 670
|
artikel
|
| 34 |
Reply to Third consensus on medical treatment of metastatic breast cancer
|
Köstler, W.J.
|
|
|
21 |
3 |
p. 665-666
|
artikel
|
| 35 |
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 ‘clinically aggressive’ cases
|
Righi, L.
|
|
|
21 |
3 |
p. 548-555
|
artikel
|
| 36 |
Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience
|
Edwards-Bennett, S.M.
|
|
|
21 |
3 |
p. 574-581
|
artikel
|
| 37 |
Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trial
|
Methy, N.
|
|
|
21 |
3 |
p. 518-524
|
artikel
|
| 38 |
Table of Contents
|
|
|
|
21 |
3 |
p. iv-vi
|
artikel
|
| 39 |
The geography of clinical cancer research: analysis of abstracts presented at the American Society of Clinical Oncology Annual Meetings
|
Saad, E.D.
|
|
|
21 |
3 |
p. 627-632
|
artikel
|
| 40 |
The location of lymphangiogenesis is an independent prognostic factor in rectal cancers with or without preoperative radiotherapy
|
Holmqvist, A.
|
|
|
21 |
3 |
p. 512-517
|
artikel
|
| 41 |
Third consensus on medical treatment of metastatic breast cancer
|
Berthold, D.
|
|
|
21 |
3 |
p. 665
|
artikel
|
| 42 |
Trastuzumab-related thrombocytopenia: always a self-limiting complication?
|
Drudi, F.
|
|
|
21 |
3 |
p. 668-669
|
artikel
|
| 43 |
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
|
Duffy, M.J.
|
|
|
21 |
3 |
p. 441-447
|
artikel
|
Tijdschrift beschrijving